Medications that inhibit CYP2D6 activity, like paroxetine and quinidine, could result in reduced clearance of oxycodone which could lead to a rise in oxycodone plasma concentrations. Concurrent administration of quinidine resulted in an increase in oxycodone Cmax by 11%, AUC by thirteen%, and t½ elim.As with all opioid preparations, oxycodone merc

Article Under Review